Oxford Vaccine Group - Home — Oxford Vaccine Group

Our Mission

To drive scientific discovery, develop innovative vaccines, and share knowledge that delivers lasting impact for all.

Find out more ❯

Latest News

Entebbe, Uganda – 6 October 2026 – The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV). The study is part of an international effort to develop vaccines against Ebola virus species for which no licensed vaccines are currently available.

Uganda launches Phase I clinical study of ChAdOx1 BDBV vaccine

The Oxford Vaccine Group has reached an important milestone in the BD-Ebov clinical trial, with the first five participants now vaccinated as part of the study's sentinel group.

BD-Ebov trial advances following completion of sentinel vaccinations

Friday 24th July, Oxford - The University of Oxford’s Oxford Vaccine Group has successfully vaccinated the first volunteer in the world’s first clinical trial of a vaccine designed to protect against Bundibugyo ebolavirus (BDBV).

First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial

More news ❯

Information about the MenB vaccination programme for previous MenB Study Participants ❯❯

Be part of the story.

Join 30 years of vaccine research that saves lives and find a study that suits you.

Find your study ❯

Protecting children worldwide

10 million doses of a typhoid conjugate vaccine we tested were used to stop an outbreak of extraordinarily resistant typhoid in Pakistan in 2019.

_{learn more ❯}

Responding to global crises

The Oxford-AstraZeneca vaccine
saved 6.3 million lives in the first year of
the global vaccine rollout during the COVID-19 pandemic.

_{learn more ❯}

Join the team.

Whether you work at the bench, the bedside, or somewhere in between, you can play a vital role in advancing vaccine science.

Explore our current vacancies and DPhil opportunities, and take your next step in shaping the future of vaccines with us.

Work with us ❯

Study with us ❯

Current Studies

ReSET

Help us learn about the leading cause of healthcare infections
PCV15-PCV20

Are your baby’s 8-week vaccination coming up? Then they maybe eligible to help our research.
NAVIGATE

Understanding public opinion on vaccinating teenagers against gonorrhoea
BIO-005 Malaria Vaccine and Challenge Study

Help us find a safe and effective malaria vaccine!